Veraxa (VRXA) news
Recent news
Veraxa Biotech Holding AG - files to register resale of up to 25 mln ordinary shares - SEC filing
Veraxa Biotech Holding AG has filed with the U.S. Securities and Exchange Commission (SEC) to register the resale of up to 25 million ordinary shares, according to a recent SEC filing. The registration is part of a broader capital-raising initiative by the company, which is in the process of…
AInvest Wire · Jul 31, 2026Veraxa Biotech shareholders approve all proposals at extraordinary general meeting, strengthening strategic flexibility for future growth
Veraxa Biotech shareholders approved all proposals presented at an extraordinary general meeting held recently, granting the company enhanced strategic flexibility to pursue future growth opportunities. The proposals included adjustments to the company’s share authorization and modifications to its…
AInvest Wire · Jul 24, 2026Veraxa Biotech names Carl von Halem as interim CFO
AInvest Wire · Jul 10, 2026Veraxa Biotech AG appoints Carl von Halem as interim chief financial officer and successor to Torsten Bürgermeister
Veraxa Biotech AG has announced the appointment of Carl von Halem as interim Chief Financial Officer (CFO), succeeding Torsten Bürgermeister. The transition follows Bürgermeister’s decision to step down from his role, though the company has not disclosed the specific reasons for the change. Von…
AInvest Wire · Jul 10, 2026Veraxa Biotech AG - targets VXA-102 IND/CTA-ready by beginning of 2028
AInvest Wire · Jul 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.